Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia-Reference-Cited by-同舟云学术

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

Published:2015-02-05 Issue:5 Volume:29 Page:999-1003
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Cross N C P,White H E,Colomer D,Ehrencrona H,Foroni L,Gottardi E,Lange T,Lion T,Machova Polakova K,Dulucq S,Martinelli G,Oppliger Leibundgut E,Pallisgaard N,Barbany G,Sacha T,Talmaci R,Izzo B,Saglio G,Pane F,Müller M C,Hochhaus A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201529.pdf

Reference34 articles.

1. Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 2013; 122: 872–884.

2. O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E et al. Chronic myelogenous leukemia, version 1.2015. `J Natl Compr Canc Netw 2014; 12: 1590–1610.

3. Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 2006; 108: 28–37.

4. Cross NC . Standardisation of molecular monitoring for chronic myeloid leukaemia. Best Pract Res Clin Haematol 2009; 22: 355–365.

5. Branford S, Cross NC, Hochhaus A, Radich J, Saglio G, Kaeda J et al. Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. Leukemia 2006; 20: 1925–1930.

Cited by 281 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population;BMC Cancer;2024-06-14

2. Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study;Frontiers in Oncology;2024-05-08

3. Chronic myeloid leukaemia: Biology and therapy;Blood Reviews;2024-05

4. Measurable residual disease (MRD)-testing in haematological and solid cancers;Leukemia;2024-04-18

5. Laboratory-developed Droplet Digital PCR Assay for Quantification of the JAK2V617F Mutation;Global Medical Genetics;2024-04-04